17 results on '"D. Reihmane"'
Search Results
2. Poster session 2
- Author
-
J. M. Perez-Pomares, A. Ruiz-Villalba, A. Ziogas, J. C. Segovia, M. Ehrbar, R. Munoz-Chapuli, A. De La Rosa, J. N. Dominguez, L. Hove-Madsen, B. Sankova, D. Sedmera, D. Franco, A. Aranega Jimenez, G. Babaeva, N. Chizh, S. Galchenko, B. Sandomirsky, M. Schwarzl, S. Seiler, P. Steendijk, S. Huber, H. Maechler, M. Truschnig-Wilders, B. Pieske, H. Post, S. Simrick, R. Kreutzer, C. Rao, C. M. Terracciano, P. Kirchhof, L. Fabritz, T. Brand, M. Theveniau-Ruissy, P. Parisot, A. Francou, E. Saint-Michel, K. Mesbah, R. G. Kelly, H.-T. Wu, S.-S. Sie, C.-Y. Chen, T.-C. Kuan, C. S. Lin, Z. Ismailoglu, M. Guven, A. Yakici, Y. Ata, S. Ozcan, E. Yildirim, Z. Ongen, V. Miroshnikova, E. Demina, T. Rodygina, P. Kurjanov, A. Denisenko, A. Schwarzman, A. Rubanenko, Y. Shchukin, A. Germanov, M. Goldbergova, J. Parenica, J. Lipkova, N. Pavek, P. Kala, M. Poloczek, A. Vasku, I. Parenicova, J. Spinar, C. Gambacciani, E. Chiavacci, M. Evangelista, N. Vesentini, C. Kusmic, L. Pitto, A. Chernova, S. U. Y. Nikulina, D. A. Arvanitis, I. Mourouzis, C. Pantos, E. G. Kranias, D. V. Cokkinos, D. Sanoudou, T. E. Vladimirskaya, I. A. Shved, S. G. Kryvorot, I. M. Schirmer, A. Appukuttan, L. Pott, K. Jaquet, Y. Ladilov, C. R. Archer, M. D. Bootman, H. L. Roderick, A. Fusco, D. Sorriento, G. Santulli, B. Trimarco, G. Iaccarino, M. Hagenmueller, J. Riffel, E. Bernhold, H. A. Katus, S. E. Hardt, A. Maqsood, M. Zi, S. Prehar, L. Neyses, S. Ray, D. Oceandy, N. Khatami, P. Wadowski, V. Wagh, J. Hescheler, A. Sachinidis, W. Mohl, B. Chaudhry, D. Burns, D. J. Henderson, N. A. M. Bax, M. H. Van Marion, B. Shah, M. J. Goumans, C. V. C. Bouten, D. W. J. Van Der Schaft, A. A. M. Van Oorschot, S. Maas, J. Braun, J. Van Tuyn, A. A. F. De Vries, A. C. Gittenberger-De Groot, S. Bageghni, M. J. Drinkhill, T. F. C. Batten, J. F. X. Ainscough, B. Onate, G. Vilahur, R. Ferrer-Lorente, J. Ybarra, A. Diez-Caballero, C. Ballesta-Lopez, F. Moscatiello, J. Herrero, L. Badimon, E. Martin-Rendon, D. M. Clifford, S. A. Fisher, S. J. Brusnkill, C. Doree, A. Mathur, M. Clarke, S. M. Watt, R. Hernandez-Vera, D. Kavanagh, A. I. Yemm, J. Frampton, N. Kalia, Y. Terajima, T. Shimizu, S. Tsuruyama, H. Ishii, H. Sekine, N. Hagiwara, T. Okano, K. R. Vrijsen, S. A. J. Chamuleau, J. P. G. Sluijter, P. F. M. Doevendans, R. Madonna, S. Delli Pizzi, L. Di Donato, A. Mariotti, L. Di Carlo, E. D'ugo, M. A. Teberino, A. Merla, A. T, R. De Caterina, L. Kolker, N. N. Ali, K. Maclellan, M. Moore, J. Wheeler, S. E. Harding, R. A. Fleck, J. M. Rowlinson, N. Kraenkel, R. Ascione, P. Madeddu, J. F. O'sullivan, A. L. Leblond, G. Kelly, A. H. S. Kumar, P. Metharom, C. K. Buneker, N. Alizadeh-Vikali, B. G. Hynes, R. O'connor, N. M. Caplice, M. Noseda, A. J. De Smith, T. Leja, P. H. Rao, F. Al-Beidh, M. S. Abreu Pavia, A. I. Blakemore, M. D. Schneider, K. Stathopoulou, F. Cuello, E. Ehler, R. S. Haworth, M. Avkiran, H. Morawietz, C. Eickholt, H. Langbein, M. Brux, C. Goettsch, W. Goettsch, A. Arsov, C. Brunssen, L. Mazilu, I. R. Parepa, A. I. Suceveanu, A. P. Suceveanu, F. S. De Man, C. Guignabert, L. Tu, M. L. Handoko, I. Schalij, E. Fadel, P. E. Postmus, A. Vonk-Noordegraaf, M. Humbert, S. Eddahibi, C. Del Giudice, A. Anastasio, L. Fazal, F. Azibani, N. Bihry, R. Merval, E. Polidano, J.-L. Samuel, C. Delcayre, Y. Zhang, Y. M. Mi, L. L. Ren, Y. P. Cheng, R. Guo, Y. Liu, Y. N. Jiang, A. D. Kokkinos, P. Tretjakovs, A. Jurka, I. Bormane, I. Mikelsone, D. Reihmane, K. Elksne, G. Krievina, J. Verbovenko, G. Bahs, N. Lopez-Andres, A. Rousseau, L. Calvier, R. Akhtar, C. Labat, K. Cruickshank, J. Diez, F. Zannad, P. Lacolley, P. Rossignol, K. Hamesch, P. Subramanian, X. Li, A. Thiemann, K. Heyll, K. Dembowsky, E. Chevalier, C. Weber, A. Schober, L. Yang, G. Kim, B. Gardner, J. Earley, M. Hofmann-Bowman, C.-F. Cheng, W.-S. Lian, H. Lin, N. J. Jinjolia, G. A. Abuladze, S. H. T. Tvalchrelidze, I. Khamnagadaev, M. Shkolnikova, L. Kokov, I. Miklashevich, I. Drozdov, I. Ilyich, B. O. Bingen, S. F. A. Askar, D. L. Ypey, A. Van Der Laarse, M. J. Schalij, D. A. Pijnappels, C. H. Roney, F. S. Ng, R. A. Chowdhury, E. T. Y. Chang, P. M. Patel, A. R. Lyon, J. H. Siggers, N. S. Peters, A. Obergrussberger, S. Stoelzle, A. Bruggemann, C. Haarmann, M. George, N. Fertig, D. Moreira, A. Souza, P. Valente, J. Kornej, C. Reihardt, J. Kosiuk, A. Arya, G. Hindricks, V. Adams, D. Husser, A. Bollmann, P. Camelliti, J. Dudhia, P. Dias, J. Cartledge, D. J. Connolly, M. Nobles, S. Sebastian, A. Tinker, A. Opel, H. Daimi, A. Haj Khelil, J. Be Chibani, A. Barana, I. Amoros, M. Gonzalez De La Fuente, R. Caballero, A. Aranega, A. Kelly, O. Bernus, O. J. Kemi, R. C. Myles, I. A. Ghouri, F. L. Burton, G. L. Smith, M. Del Lungo, L. Sartiani, V. Spinelli, M. Baruscotti, D. Difrancesco, A. Mugelli, E. Cerbai, A. M. Thomas, Q. Aziz, T. Khambra, J. M. A. Addlestone, E. J. Cartwright, R. Wilkinson, W. Song, S. Marston, A. Jacquet, N. M. Mougenot, A. J. Lipskaia, E. R. Paalberends, K. Stam, S. J. Van Dijk, M. Van Slegtenhorst, C. Dos Remedios, F. J. Ten Cate, M. Michels, H. W. M. Niessen, G. J. M. Stienen, J. Van Der Velden, M. I. Read, A. A. Andreianova, J. C. Harrison, C. S. Goulton, D. S. Kerr, I. A. Sammut, M. Wallner, D. Von Lewinski, D. Kindsvater, M. Saes, I. Morano, A. Muegge, B. Buyandelger, S. Kostin, S. Gunkel, J. Vouffo, K. Ng, J. Chen, M. Eilers, R. Isaacson, H. Milting, R. Knoell, M.-E. Cattin, C. Crocini, S. Schlossarek, S. Maron, A. Hansen, T. Eschenhagen, L. Carrier, G. Bonne, R. Coppini, C. Ferrantini, I. Olivotto, L. Belardinelli, C. Poggesi, M. C. Leung, A. E. Messer, O. Copeland, S. B. Marston, A. M. Mills, T. Collins, P. O'gara, T. Thum, K. Regalla, K. T. Macleod, T. Prodromakis, U. Chaudhry, A. Darzi, M. H. Yacoub, T. Athanasiou, A. Bogdanova, A. Makhro, M. Hoydal, T. O. Stolen, A. B. Johnssen, M. Alves, D. Catalucci, G. Condorelli, L. G. Koch, S. L. Britton, U. Wisloff, V. Bito, P. Claus, K. Vermeulen, C. Huysmans, R. Ventura-Clapier, K. R. Sipido, M. N. Seliuk, A. P. Burlaka, E. P. Sidorik, N. V. Khaitovych, M. M. Kozachok, V. S. Potaskalova, R. B. Driesen, D. T. Galan, D. De Paulis, T. Arnoux, S. Schaller, R. M. Pruss, D. M. Poitz, A. Augstein, R. C. Braun-Dullaeus, A. Schmeisser, R. H. Strasser, P. Micova, P. Balkova, M. Hlavackova, J. Zurmanova, D. Kasparova, F. Kolar, J. Neckar, F. Novak, O. Novakova, S. Pollard, M. Babba, A. Hussain, R. James, H. Maddock, A. S. Alshehri, G. F. Baxter, B. Dietel, R. Altendorf, W. G. Daniel, R. Kollmar, C. D. Garlichs, R. Sirohi, N. Roberts, D. Lawrence, A. Sheikh, S. Kolvekar, J. Yap, M. Arend, G. Walkinshaw, D. J. Hausenloy, D. M. Yellon, A. Posa, R. Szabo, Z. Szalai, P. Szablics, M. A. Berko, K. Orban, Z. S. Murlasits, L. Balogh, C. Varga, H. C. Ku, M. J. Su, R.-M. Chreih, C. Ginghina, D. Deleanu, A. L. B. J. Ferreira, A. Belal, M. A. Ali, X. Fan, A. Holt, R. Campbell, R. Schulz, C. Bonanad, V. Bodi, J. Sanchis, J. M. Morales, V. Marrachelli, J. Nunez, M. J. Forteza, F. Chaustre, C. Gomez, F. J. Chorro, T. Csont, V. Fekete, Z. Murlasits, E. Aypar, P. Bencsik, M. Sarkozy, Z. V. Varga, P. Ferdinandy, G. D. Duerr, M. Zoerlein, D. Dewald, B. Mesenholl, P. Schneider, A. Ghanem, S. Rittling, A. Welz, O. Dewald, E. Becker, C. Peigney, C. Bouleti, A. Galaup, C. Monnot, B. Ghaleh, S. Germain, A. Timmermans, A. Ginion, C. De Meester, K. Sakamoto, J.-L. Vanoverschelde, S. Horman, C. Beauloye, L. Bertrand, N. Maroz-Vadalazhskaya, E. Drozd, L. Kukharenko, I. Russkich, D. Krachak, Y. Seljun, Y. Ostrovski, A.-C. Martin, B. Le Bonniec, T. Lecompte, B. Dizier, J. Emmerich, A.-M. Fischer, C.-M. Samama, A. Godier, S. Mogensen, E. M. Furchtbauer, C. Aalkjaer, W. L. Choong, A. Jovanovic, F. Khan, J. M. Daniel, J. M. Dutzmann, R. Widmer-Teske, D. Guenduez, D. Sedding, M. M. Castro, J. J. C. Cena, W. J. C. Cho, G. G. Goobie, M. P. W. Walsh, R. S. Schulz, J. Dutzmann, K. T. Preissner, W. Sones, M. Kotlikoff, K. Serizawa, K. Yogo, K. Aizawa, M. Hirata, Y. Tashiro, N. Ishizuka, A. Varela, M. Katsiboulas, D. Tousoulis, T. G. Papaioannou, S. Vaina, C. H. Davos, C. Piperi, C. Stefanadis, E. K. Basdra, A. G. Papavassiliou, C. Hermenegildo, M. Lazaro-Franco, A. Sobrino, C. Bueno-Beti, N. Martinez-Gil, T. Walther, C. Peiro, C. F. Sanchez-Ferrer, S. Novella, M. Ciccarelli, A. Franco, G. W. Dorn, P. Cseplo, O. Torok, Z. S. Springo, Z. Vamos, D. Kosa, J. Hamar, A. Koller, K. J. Bubb, A. Ahluwalia, E. L. Stepien, A. Gruca, J. Grzybowska, J. Goralska, A. Dembinska-Kiec, J. Stolinski, L. Partyka, H. Zhang, D. Sweeney, G. N. Thomas, P. V. Fish, D. P. Taggart, S. Cioffi, M. Bilio, S. Martucciello, E. Illingworth, A. Caporali, S. Shantikumar, M. Marchetti, F. Martelli, C. Emanueli, M. Meloni, A. Al Haj Zen, G. Sala-Newby, S. Del Turco, C. Saponaro, B. Dario, S. Sartini, A. Menciassi, P. Dario, C. La Motta, G. Basta, V. Santiemma, C. Bertone, F. Rossi, E. Michelon, M. J. Bianco, A. Castelli, D. I. Shin, K. B. Seung, S. M. Seo, H. J. Park, P. J. Kim, S. H. Baek, Y. S. Choi, S. H. Her, D. B. Kim, J. M. Lee, C. S. Park, S. Rocchiccioli, A. Cecchettini, G. Pelosi, L. Citti, O. Parodi, M. G. Trivella, D. Michel-Monigadon, F. Burger, S. Dunoyer-Geindre, G. Pelli, B. Cravatt, S. Steffens, A. Didangelos, U. Mayr, X. Yin, C. Stegemann, J. Shalhoub, A. H. Davies, C. Monaco, M. Mayr, S. Lypovetska, S. Grytsenko, I. U. Njerve, A. A. Pettersen, T. B. Opstad, V. Bratseth, H. Arnesen, I. Seljeflot, I. E. Dumitriu, P. Baruah, R. F. Antunes, J. C. Kaski, I. Trapero, I. Benet, C. Alguero, F. J. Chaustre, A. Mangold, S. Puthenkalam, K. Distelmaier, C. Adlbrecht, I. M. Lang, T. Koizumi, I. Inoue, N. Komiyama, S. Nishimura, O. N. Korneeva, O. M. Drapkina, L. Fornai, A. Angelini, A. Kiss, F. Giskes, G. Eijkel, M. Fedrigo, M. L. Valente, G. Thiene, R. M. A. Heeren, T. Padro, L. Casani, R. Suades, B. Bertoni, R. Carminati, V. Carlini, L. Pettinari, C. Martinelli, N. Gagliano, G. Noppe, P. Buchlin, N. Marquet, N. Baeyens, N. Morel, A. Baysa, J. Sagave, C. P. Dahl, L. Gullestad, A. Carpi, F. Di Lisa, M. Giorgio, J. Vaage, G. Valen, E. Vafiadaki, V. Papalouka, G. Terzis, K. Spengos, P. Manta, C. Gales, G. Genet, E. Dague, O. Cazorla, B. Payre, C. Mias, A. Ouille, A. Lacampagne, A. Pathak, J. M. Senard, M. Abonnenc, P. Da Costa Martins, S. Srivastava, M. Gautel, L. De Windt, L. Comelli, C. Lande, N. Ucciferri, L. Ikonen, H. Vuorenpaa, K. Kujala, J.-R. Sarkanen, T. Heinonen, T. Ylikomi, K. Aalto-Setala, H. Capros, N. Sprincean, N. Usurelu, V. Egorov, N. Stratu, V. Matchkov, E. Bouzinova, N. Moeller-Nielsen, O. Wiborg, P. S. Gutierrez, R. Aparecida-Silva, L. F. Borges, L. F. P. Moreira, R. R. Dias, J. Kalil, N. A. G. Stolf, W. Zhou, K. Suntharalingam, N. Brand, R. Vilar Compte, L. Ying, K. Bicknell, A. Dannoura, P. Dash, G. Brooks, I. Tsimafeyeu, Y. Tishova, N. Wynn, I. P. Oyeyipo, L. A. Olatunji, L. Maegdefessel, J. Azuma, R. Toh, U. Raaz, D. R. Merk, A. Deng, J. M. Spin, P. S. Tsao, L. Tedeschi, M. Taranta, I. Naldi, S. Grimaldi, C. Cinti, M. Bousquenaud, F. Maskali, S. Poussier, P. Y. Marie, H. Boutley, G. Karcher, D. R. Wagner, Y. Devaux, I. Torre, S. Psilodimitrakopoulos, I. Iruretagoiena, A. Gonzalez-Tendero, D. Artigas, P. Loza-Alvarez, E. Gratacos, I. Amat-Roldan, L. Murray, D. M. Carberry, P. Dunton, M. J. Miles, M.-S. Suleiman, K. Kanesalingam, R. Taylor, C. N. Mc Collum, A. Parniczky, M. Solymar, A. Porpaczy, A. Miseta, Z. S. Lenkey, S. Szabados, A. Cziraki, J. Garai, I. Myloslavska, S. M. Menazza, M. C. Canton, F. D. L. Di Lisa, S. H. V. Oliveira, C. A. S. Morais, M. R. Miranda, T. T. Oliveira, M. R. A. Lamego, L. M. Lima, N. S. Goncharova, A. V. Naymushin, A. V. Kazimli, O. M. Moiseeva, M. G. Carvalho, A. P. Sabino, A. P. L. Mota, M. O. Sousa, A. Niessner, B. Richter, P. J. Hohensinner, K. Rychli, G. Zorn, R. Berger, D. Moertl, R. Pacher, J. Wojta, M. Huelsmann, G. Kukharchik, N. Nesterova, A. Pavlova, L. Gaykovaya, N. Krapivka, I. Konstantinova, L. Sichinava, S. Prapa, K. P. Mccarthy, P. J. Kilner, X. Y. Xu, M. R. Johnson, S. Y. Ho, M. A. Gatzoulis, E. G. Stoupel, R. Garcia, D. Merino, C. Montalvo, M. A. Hurle, J. F. Nistal, A. V. Villar, A. Perez-Moreno, R. Gilabert, and E. Ros
- Subjects
medicine.medical_specialty ,Endocrinology ,Physiology ,Activator (genetics) ,Chemistry ,Physiology (medical) ,Internal medicine ,medicine ,AMPK ,Myocyte ,Long-term potentiation ,Metabolism ,Cardiology and Cardiovascular Medicine - Published
- 2012
3. The relationship between maximal exercise-induced increases in serum IL-6, MPO and MMP-9 concentrations
- Author
-
D, Reihmane, A, Jurka, and P, Tretjakovs
- Subjects
Adult ,Male ,Hockey ,Matrix Metalloproteinase 9 ,Interleukin-6 ,Humans ,Exercise ,Peroxidase - Abstract
The aim of this study was to test the hypothesis that exercise would induce inflammatory response characterized by increased pro-inflammatory cytokines - interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α), adhesion molecule, matrix metalloprotease-9 (MMP-9) and myeloperoxidase (MPO) levels. Additional aim was to elucidate the possible source of maximal exercise-induced increase in MMP-9 concentration. To examine our hypothesis, 26 professional male ice hockey players [age 25 ± 1 (mean ± SEM) years; BMI 25.8 ± 0.4 kg/m(2) ] performed an incremental bicycle test until exhaustion, when maximal oxygen consumption was recorded. Venous blood samples were collected 30 min before and 2 min after exercise. There was an increase in the count of leucocytes (8.7 ± 1.8 versus 5.7 ± 1.3 × 10(9) cells per l) and IL-6 (1.24 ± 0.17 versus 0.69 ± 0.13 pg/ml), MPO (72 ± 7 versus 50 ± 4 ng/ml) and MPP-9 (139 ± 9 versus 110 ± 6 ng/ml) concentrations (P0.05) comparing post- and pre-exercise levels. Maximal exercise-induced increase in MPO correlated with the increases in IL-6 (P0.05, R = 0.54) and MMP-9 (P0.01, R = 0.62) concentrations. Furthermore, increase in IL-6 correlated with the increase in MMP-9 concentrations (P0.05, R = 0.60). Maximal exercise induces an inflammatory response characterized by leucocytosis and increased IL-6, MPO and MMP-9 concentrations. Correlations between increased MPO (marker of neutrophils degranulation) and both increased IL-6 and MMP-9 concentrations may suggest that neutrophils could be the main source of these inflammatory biomarkers during maximal exercise. Furthermore, correlation between increases in serum IL-6 and MMP-9 concentrations may suggest that IL-6 could exert modulatory effects on MMP-9 release during maximal exercise.
- Published
- 2012
4. Relations between the levels of moderate to vigorous physical activity, BMI, dietary habits, cognitive functions and attention problems in 8 to 9 years old pupils: network analysis (PACH Study).
- Author
-
Raudeniece J, Vanags E, Justamente I, Skara D, Fredriksen PM, Brownlee I, and Reihmane D
- Subjects
- Child, Humans, Body Mass Index, Feeding Behavior, Cognition, Quality of Life, Exercise
- Abstract
Background: Physical activity (PA) and dietary habits (DH) play a crucial role on quality of life and health outcomes from various aspects., Methods: This study aims to investigate the relations between recommended daily levels of moderate to vigorous physical activity (MVPA) in 8 to 9 year old pupils, and their body mass index (BMI), DH, cognitive functions and attention problem scores by network analysis. Study participants were split into two groups based on their MVPA levels on weekdays., Results: Our findings suggest that children who reach recommended MVPA levels consume more vegetables and fruits, eat breakfast more frequently, have better motor speed and lower impulsivity score., Conclusions: The number of interlinkages between various parameters in network structure for children who do not reach recommended MVPA levels is greater and more intense, highlighting the differences between the groups and suggesting that different interventions and approaches to improve/change lifestyle habits might be used., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
5. In Vitro Safety and Efficacy Evaluation of a Juniperus communis Callus Culture Extract and Matricaria recutita Processing Waste Extract Combination as a Cosmetic Ingredient.
- Author
-
Ramata-Stunda A, Boroduskis M, Pastare L, Berga M, Kienkas L, Patetko L, Skudrins G, Reihmane D, and Nakurte I
- Abstract
For skin health promotion and cosmetic applications, combinations of plant cell extracts are extensively utilized. As most natural ingredient suppliers offer crude extracts from individual plants or specific isolated compounds, the potential interactions between them are assessed in the development phase of cosmetic products. The industry seeks extract combinations that have undergone optimization and scrutiny for their bioactivities. This study presents a combination of two sustainably produced botanical ingredients and outlines their chemical composition, in vitro safety, and bioactivity for skin health enhancement. The amalgamation comprises the extract of Matricaria recutita processing waste and the extract from Juniperus communis callus culture. Chemical analysis revealed distinct compounds within the extracts, and their combination led to a broader array of potentially synergistic compounds. In vitro assessments on skin cells demonstrated that the combination possesses robust antioxidant properties and the ability to stimulate keratinocyte proliferation, along with regulating collagen type I and matrix metalloproteinase 1 (MMP-1) production by dermal fibroblasts. The identified traits of this combination render it an appealing cosmetic component. To the best of our knowledge, this represents the first case when the extracts derived from medicinal plant processing waste and biotechnological plant cell cultivation processes have been combined and evaluated for their bioactivity.
- Published
- 2024
- Full Text
- View/download PDF
6. Circulating sestrins and force velocity profiling in older adults with type 2 diabetes.
- Author
-
González-Martos R, Aparicio-Ugarriza R, Alcazar J, Ramirez-Castillejo C, Reihmane D, Menéndez-Rey A, González-Gross M, and Guadalupe-Grau A
- Subjects
- Humans, Aged, Muscle, Skeletal physiology, Body Composition, Biomarkers, Muscle Strength physiology, Sestrins, Diabetes Mellitus, Type 2
- Abstract
Type 2 diabetes mellitus (T2DM) in old age affects the musculoskeletal system causing loss of muscle mass, strength, and physical function. Stress-inducible proteins named sestrins are potential novel biomarkers of muscle function due to their ability to suppress oxidative stress and prevent muscle degeneration. Our aim was to determine the association between different force-velocity (F-V) profiles with body composition, physical performance, and glucose control in older adults with T2DM. We also intended to determine the potential utility of sestrin 1 (Sesn1) and 2 (Sesn2) as biomarkers of physical functionality. Fifty-nine participants (69-79 years) were classified in 3 groups according to their F-V profile based on the leg press exercise: nondeficit (N
DEF = 40.7%), force deficit (FDEF = 28.8%), and velocity deficit (VDEF = 30.5%). Both VDEF and FDEF groups showed lower muscle power than NDEF (Cohen's d 0.87 and 0.75 for effect size, respectively). Serum Sesn2 levels, maximal dynamic strength, arms and legs fat-free mass were reduced in FDEF compared to the NDEF group ( p < 0.05), whereas glycated haemoglobin (HbA1c) and fasting glucose levels were similar among groups. ROC analysis revealed the distinction between the NDEF and FDEF group based on Sesn2 concentrations (<0.72 ng/mL), suggesting their potential use as functional biomarkers for early intervention through exercise. Older adults with T2DM show different F-V profiles, related to low levels of Sesn2, impaired body composition and physical performance, and may be taken into consideration to target exercise training in this specific population. Highlights The influence of different F-V deficit profiles on body composition, physical function and circulating sestrins in older adults with type 2 diabetes were studied.Both force and velocity deficits negatively affected muscle power.Force deficits are associated to low circulating sestrin 2 levels and regional fat-free mass.Basal serum sestrin 2 levels are potential biomarkers to characterise F-V profiles.- Published
- 2023
- Full Text
- View/download PDF
7. Exploring the Potential of Supercritical Fluid Extraction of Matricaria chamomilla White Ray Florets as a Source of Bioactive (Cosmetic) Ingredients.
- Author
-
Pastare L, Berga M, Kienkas L, Boroduskis M, Ramata-Stunda A, Reihmane D, Senkovs M, Skudrins G, and Nakurte I
- Abstract
Aromatic and medicinal plants are a great source of useful bioactive compounds for use in cosmetics, drugs, and dietary supplements. This study investigated the potential of using supercritical fluid extracts obtained from Matricaria chamomilla white ray florets, a kind of industrial herbal byproduct, as a source of bioactive cosmetic ingredients. Response surface methodology to optimize the supercritical fluid extraction process by analyzing the impact of pressure and temperature on yield and the main bioactive compound groups were used. High-throughput 96-well plate spectrophotometric methods were used to analyze the extracts for total phenols, flavonoids, tannins, and sugars, as well as their antioxidant capacity. Gas chromatography and liquid chromatography-mass spectrometry was used to determine the phytochemical composition of the extracts. The extracts were also analyzed for antimicrobial activity, cytotoxicity, phototoxicity, and melanin content. Statistical analysis was performed to establish correlations between the extracts and develop models to predict the targeted phytochemical recovery and chemical and biological activities. The results show that the extracts contained a diverse range of phytochemical classes and had cytotoxic, proliferation-reducing, and antimicrobial activities, making them potentially useful in cosmetic formulations. This study provides valuable insights for further research on the uses and mechanisms of action of these extracts.
- Published
- 2023
- Full Text
- View/download PDF
8. Severe COVID-19 Pneumonia in a Three-Year-Old with Congenital Iron and B12 Deficiency Anemia of Unknown Etiology: A Case Report.
- Author
-
Liapman TD, Bormotovs J, and Reihmane D
- Abstract
Since COVID-19 first emerged in Wuhan, China, and was declared a global pandemic by the WHO, researchers have been meticulously studying the disease and its complications. Studies of severe COVID-19 disease among pediatric populations are scarce, leading to difficulty in establishing a comprehensive management approach. Case presentation: This report outlines a case of a long-standing combined iron and vitamin B12 deficiency anemia in a three-year-old treated at the Children's Clinical University Hospital due to severe COVID-19 disease. The patient's clinical condition coincided with the derangement of biomarkers described in the literature, including lymphopenia, increased neutrophil/lymphocyte ratio (NLR), decreased lymphocyte/C-reactive protein ratio (LCR), as well as elevated inflammatory markers such as CRP and D-dimers. The patient developed severe bilateral pneumonia requiring invasive ventilation, high-flow oxygen, immunosuppressive therapy with dexamethasone and tocilizumab, and supplementation of anemia deficits with blood transfusion and vitamin B12 administration. Conclusions: Our findings are consistent with the most important biomarkers reported in the literature indicative of severe disease progression. Additionally, poorly controlled anemia may be suggested as a potentially important risk factor for severe COVID-19 disease among children. However, additional quantitative research is required to establish the nature and severity of the risk.
- Published
- 2023
- Full Text
- View/download PDF
9. Multicomponent Home-Based Training Program for Chronic Kidney Disease Patients during Movement Restriction.
- Author
-
López-Torres O, Azpeitia-Martínez C, González-Gross M, Reihmane D, and Guadalupe-Grau A
- Subjects
- Humans, Pandemics, SARS-CoV-2, COVID-19, Kidney Failure, Chronic therapy, Renal Insufficiency, Chronic therapy
- Abstract
Both intradialytic and out-of-clinic exercise programs (EP) have been proven to be a safe and effective way to increase fitness levels in end-stage chronic kidney disease (CKD) patients. The actual COVID-19 pandemic situation has forced the suspension of EP offered in hemodialysis centers in many countries; as well as all activities considered as "non-essential" (i.e., sport facilities and fitness centers). Therefore, there is a high risk that movement restrictions would promote physical inactivity and its associated diseases in CKD patients; especially those undergoing domiciliary confinement situations. Given the importance for CKD patients' overall health to maintain exercise levels and reach physical activity recommendations, the aim of this Protocol was to design a personalized, well-structured, multicomponent physical EP that CKD patients can safely follow at home. We also aimed to provide an initial fitness evaluation tool that allows patients to adapt the EP to their fitness level. Current general exercise recommendations for people living with chronic conditions have been analyzed to develop the present home-based EP proposal.
- Published
- 2021
- Full Text
- View/download PDF
10. Comparative Analysis of the Effects of Daily Eating Habits and Physical Activity on Anthropometric Parameters in Elementary School Children in Latvia: Pach Study.
- Author
-
Justamente I, Raudeniece J, Ozolina-Moll L, Guadalupe-Grau A, and Reihmane D
- Subjects
- Anthropometry, Body Height, Body Mass Index, Body Weight, Child, Cross-Sectional Studies, Diet Surveys, Female, Humans, Latvia epidemiology, Male, Schools, Waist Circumference, Diet, Healthy statistics & numerical data, Exercise, Feeding Behavior, Pediatric Obesity epidemiology, Students statistics & numerical data
- Abstract
Growing incidence of obesity and related diseases in children poses new challenges and calls for a review of lifestyle habits. This study aimed to assess daily eating habits (EH) and physical activity (PA) levels and identify their association with obesity in 8-10-year-old children. Children's EH and time spent in moderate-to-vigorous physical intensity (MVPA) was estimated from questionnaires ( N = 1788). Weight, height, and waist circumference (WC) were collected, and body mass index (BMI) calculated. Girls consumed more fruits and vegetables, drank more water, and ate smaller portions of carbohydrate and protein rich foods but spent less time in MVPA compared to boys ( p < 0.05). Obese children skipped breakfast more often and consumed less fruits and vegetables. Children who chose to eat in front of the screen had higher WC (62.88 ± 8.70 vs 60.59 ± 7.40 cm, p < 0.001) and higher BMI, and chose smaller vegetable portions and more calorie dense snacks ( p < 0.001). 15.4% of pupils covered weekly MVPA recommendations with structured PA on weekdays. Increasing MVPA was related to a smaller number of unhealthy EH ( p < 0.001). In conclusion, EH and PA levels differ between sexes and obese children have unhealthier EH. Higher levels of MVPA are related to healthier food choices, while pupils having meals in front of the screen have unhealthier EH and anthropometric measures. The majority of pupils did not reach the WHO recommendations of MVPA through structured PA on weekdays. Association between factors (EH and time spent in PA) and BMI was not found in this study.
- Published
- 2020
- Full Text
- View/download PDF
11. Exercise promotes IL-6 release from legs in older men with minor response to unilateral immobilization.
- Author
-
Reihmane D, Gram M, Vigelsø A, Wulff Helge J, and Dela F
- Subjects
- Aged, Cohort Studies, Humans, Interleukin-6 blood, Male, Tumor Necrosis Factor-alpha blood, Tumor Necrosis Factor-alpha metabolism, Exercise physiology, Interleukin-6 metabolism, Leg physiology, Restraint, Physical
- Abstract
Physical inactivity is a major contributor to low-grade systemic inflammation. Most of the studies characterizing interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) release from exercising legs have been done in young, healthy men, but studies on inactivity in older people are lacking. The impact of 14 days of one-leg immobilization (IM) on IL-6 and TNF-α release during exercise in comparison to the contralateral control (CON) leg was investigated. Fifteen healthy men (age 68.1 ± 1.1 year (mean ± SEM); BMI 27.0 ± 0.4 kg·m(2); VO2max 33.3 ± 1.6 ml·kg(‒1)·min(‒1)) performed 45 min of two-leg dynamic knee extensor exercise at 19.5 ± 0.9 W. Arterial and femoral venous blood samples from the CON and the IM legs were collected every 15 min during exercise, and thigh blood flow was measured with ultrasound Doppler. Arterial plasma IL-6 concentration increased with exercise (rest vs. 45 min, main effect p < .05). IL-6 release increased with exercise (rest vs. 30 min, main effect p < .05). Furthermore, IL-6 release was borderline (main effect, p = .085, effect size 0.28) higher in the IM leg compared to the CON leg (288 (95% CI: 213-373) vs. 220 (95% CI: 152-299) pg·min(‒1), respectively). There was no release of TNF-α in either leg and arterial concentrations remained unchanged during exercise (p > .05). In conclusion, exercise induces more pronounced IL-6 secretion in healthy older men. Two weeks of unilateral immobilization on the other hand had only a minor influence on IL-6 release. Neither immobilization nor exercise had an effect on TNF-α release across the working legs in older men.
- Published
- 2016
- Full Text
- View/download PDF
12. Interleukin-6: possible biological roles during exercise.
- Author
-
Reihmane D and Dela F
- Subjects
- Animals, Humans, Interleukin-6 blood, Muscle, Skeletal injuries, Muscle, Skeletal metabolism, Signal Transduction, Exercise physiology, Interleukin-6 metabolism
- Abstract
Interleukin-6 (IL-6) is a multifunctional cytokine that exerts its modulatory effects on cells that express membrane bound IL-6 receptors; however, IL-6 in a complex with soluble IL-6R can bind to any cell that express glycoprotein 130 (gp130). Thus, all cell types may respond to the pro- as well as anti-inflammatory properties of IL-6. Since the first report of acute exercise-induced increase in plasma IL-6 in the early 1990s, scientists have tried to elucidate the factors that influence the magnitude of change of plasma IL-6, as well as the possible biological roles of this cytokine. Evidence suggests that exercise intensity and duration as well as the form of contraction (e.g., eccentric or concentric) and muscle damage all influence IL-6 response to acute exercise. However, data on training status and performance on plasma IL-6 concentration changes during exercise are more inconclusive, as discussed in this review. In the last decade, most of the studies have focused on IL-6 as an 'energy sensor' possibly secreted by skeletal muscle that activates glycogenolysis in the liver and lipolysis in fat tissue in order to provide muscle with the growing energy demands during exercise.
- Published
- 2014
- Full Text
- View/download PDF
13. Increase in IL-6, TNF-α, and MMP-9, but not sICAM-1, concentrations depends on exercise duration.
- Author
-
Reihmane D, Jurka A, Tretjakovs P, and Dela F
- Subjects
- Adult, Analysis of Variance, Biomarkers blood, Humans, Male, Muscle, Skeletal metabolism, Running, Time Factors, Up-Regulation, Young Adult, Exercise, Inflammation Mediators blood, Intercellular Adhesion Molecule-1 blood, Interleukin-6 blood, Matrix Metalloproteinase 9 blood, Muscle Contraction, Muscle, Skeletal immunology, Physical Endurance, Tumor Necrosis Factor-alpha blood
- Abstract
It has been suggested that exercise intensity is of importance in the regulation of increase in pro-inflammatory molecules, but there is still a debate about the effect of duration on these molecules. Therefore, the effect of exercise duration on the serum concentrations of interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α), soluble form of intercellular adhesion molecule-1 (sICAM-1), and matrix metalloproteinase-9 (MMP-9) was studied in 22 half-marathon (HM) and 18 marathon (M) male amateur runners who completed their exercise task in 1.8 ± 0.2 (mean ± standard deviation) and 3.6 ± 0.4 h, respectively (thus, average speed was 11.7 ± 1.5 and 11.9 ± 1.8 km h(-1), respectively). Blood was sampled 2 days before, 15 min after, and 28 h after the race. IL-6, TNF-α, and MMP-9 always increased immediately after exercise, but the increase was larger (P < 0.05) in M versus HM (∆IL-6: 31 ± 24 vs. 5 ± 4 pg ml(-1); ∆TNF-α: 1.7 ± 1.9 vs. 0.5 ± 0.8 pg ml(-1); MMP-9: 288 ± 216 vs. 145 ± 128 ng ml(-1), respectively). sICAM-1 also increased with exercise, but similarly in M and HM (20 ± 40 vs. 23 ± 32 ng ml(-1), respectively). Only sICAM-1 remained elevated 28 h post-exercise in both HM and M, while IL-6, TNF-α, and MMP-9 returned to pre-exercise levels. Competitive HM and M races induce significant increases in IL-6, TNF-α, sICAM-1, and MMP-9 concentrations. As HM and M runners performed the competition with similar absolute intensity, the difference in response between the groups suggests that exercise duration is of importance in the regulation of IL-6, TNF-α, and MMP-9, but not sICAM-1 concentrations in response to prolonged running.
- Published
- 2013
- Full Text
- View/download PDF
14. Immobilization increases interleukin-6, but not tumour necrosis factor-α, release from the leg during exercise in humans.
- Author
-
Reihmane D, Hansen AV, Gram M, Kuhlman AB, Nørregaard J, Pedersen HP, Lund MT, Helge JW, and Dela F
- Subjects
- Exercise physiology, Exercise Test, Femoral Vein, Humans, Leg blood supply, Male, Oxygen Consumption, Regional Blood Flow physiology, Young Adult, Immobilization physiology, Interleukin-6 blood, Tumor Necrosis Factor-alpha metabolism
- Abstract
Data on interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) release during acute exercise are not conclusive, and information is lacking about the impact of physical inactivity. Some studies have shown an increase, but others report no changes in IL-6 and TNF-α release during exercise. We have now studied the temporal relationship of leg IL-6 and TNF-α release before and during isolated two-legged exercise after 14 days of one-leg immobilization (IM) while the other leg served as the control (CON) leg. Fifteen healthy male subjects (mean ± SEM age, 23 ± 1 years; body mass index, 23.6 ± 0.7 kg m(-2); and maximal oxygen uptake, 46.8 ± 1.4 ml kg(-1) min(-1)) performed 45 min of two-legged dynamic knee-extensor exercise at 19.6 ± 0.8 W. Arterial and femoral venous blood samples from the CON and the IM leg were collected every 15 min during exercise, and leg blood flow was measured with Doppler ultrasound. The arterial plasma IL-6 concentration increased (P < 0.05) with exercise (rest, 1.3 ± 0.1 pg ml(-1); 15 min, 1.9 ± 0.2 pg ml(-1); 30 min, 2.4 ± 0.2 pg ml(-1); and 45 min, 3.1 ± 0.3 pg ml(-1)). Interleukin-6 release occurred after 15 min of exercise, and the release from the IM leg was significantly greater compared with the CON leg after 45 min (1114 ± 152 versus 606 ± 14 pg min(-1), respectively, P < 0.05). Tumour necrosis factor-α release did not differ between the CON and the IM leg, and arterial concentrations remained unchanged during exercise (P > 0.05). In conclusion, prior immobilization enhances release of IL-6 from the leg during exercise at a moderate workload, and the release is already present in the early phase of exercise. Neither immobilization nor exercise had an effect on TNF-α release in the working legs.
- Published
- 2013
- Full Text
- View/download PDF
15. The relationship between maximal exercise-induced increases in serum IL-6, MPO and MMP-9 concentrations.
- Author
-
Reihmane D, Jurka A, and Tretjakovs P
- Subjects
- Adult, Humans, Male, Exercise, Hockey, Interleukin-6 blood, Matrix Metalloproteinase 9 blood, Peroxidase blood
- Abstract
The aim of this study was to test the hypothesis that exercise would induce inflammatory response characterized by increased pro-inflammatory cytokines - interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α), adhesion molecule, matrix metalloprotease-9 (MMP-9) and myeloperoxidase (MPO) levels. Additional aim was to elucidate the possible source of maximal exercise-induced increase in MMP-9 concentration. To examine our hypothesis, 26 professional male ice hockey players [age 25 ± 1 (mean ± SEM) years; BMI 25.8 ± 0.4 kg/m(2) ] performed an incremental bicycle test until exhaustion, when maximal oxygen consumption was recorded. Venous blood samples were collected 30 min before and 2 min after exercise. There was an increase in the count of leucocytes (8.7 ± 1.8 versus 5.7 ± 1.3 × 10(9) cells per l) and IL-6 (1.24 ± 0.17 versus 0.69 ± 0.13 pg/ml), MPO (72 ± 7 versus 50 ± 4 ng/ml) and MPP-9 (139 ± 9 versus 110 ± 6 ng/ml) concentrations (P < 0.05) comparing post- and pre-exercise levels. Maximal exercise-induced increase in MPO correlated with the increases in IL-6 (P < 0.05, R = 0.54) and MMP-9 (P < 0.01, R = 0.62) concentrations. Furthermore, increase in IL-6 correlated with the increase in MMP-9 concentrations (P < 0.05, R = 0.60). Maximal exercise induces an inflammatory response characterized by leucocytosis and increased IL-6, MPO and MMP-9 concentrations. Correlations between increased MPO (marker of neutrophils degranulation) and both increased IL-6 and MMP-9 concentrations may suggest that neutrophils could be the main source of these inflammatory biomarkers during maximal exercise. Furthermore, correlation between increases in serum IL-6 and MMP-9 concentrations may suggest that IL-6 could exert modulatory effects on MMP-9 release during maximal exercise., (© 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
16. Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
- Author
-
Tretjakovs P, Jurka A, Bormane I, Mikelsone I, Elksne K, Krievina G, Reihmane D, Verbovenko J, and Bahs G
- Subjects
- Aged, Angina Pectoris complications, Case-Control Studies, Coronary Artery Disease complications, Female, Humans, Insulin Resistance, Male, Middle Aged, Angina Pectoris blood, Cell Adhesion Molecules blood, Coronary Artery Disease blood, Matrix Metalloproteinase 9 blood, Peroxidase blood, Plasminogen Activator Inhibitor 1 blood
- Abstract
Background: There are many pathophysiological mechanisms underlying reciprocal relationships between changes in cytokines and insulin resistance in metabolic and cardiovascular disorders. The aim of this study was to evaluate alterations in soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), matrix metalloproteinase-9 (MMP-9), plasminogen activator inhibitor-1 (PAI-1), and myeloperoxidase (MPO) levels, and their relation to insulin resistance in coronary artery disease (CAD) patients with stable and unstable angina (SAP, UAP)., Methods: Non-diabetic CAD patients were classified into two groups: 22 patients with SAP and 22 patients with UAP. 22 healthy subjects were selected as controls. The study groups were matched for age and sex. Insulin resistance was evaluated by HOMA-IR method. Serum levels of sICAM-1, sVCAM-1, sE-selectin PAI-1(total), MPO and MMP-9 were quantified by xMAP technology (Luminex-200 analyzer)., Results: Both patient groups demonstrated significantly elevated serum levels of sICAM-1, sE-selectin, PAI-1(total), MPO and MMP-9 (p<0.05) as well as higher IR-HOMA values (p<0.05) than those of healthy controls. The elevation was more pronounced in the UAP group (p<0.01). HOMA-IR was correlated with sICAM-1, PAI-1(total), and MMP-9 (p<0.01)., Conclusion: Our findings show that CAD patients have elevated HOMA-IR values. Furthermore, CAD patients with UAP have higher levels of sICAM-1, sVCAM-1, sE-selectin, MMP-9, PAI-1(total), and MPO than patients with SAP, and there are relationships between three of the above biomarkers: sICAM-1, PAI-1(total), MMP-9 and HOMA-IR., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
17. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.
- Author
-
Tretjakovs P, Jurka A, Bormane I, Mackevics V, Mikelsone I, Balode L, Reihmane D, Stukena I, Bahs G, Aivars JI, and Pirags V
- Subjects
- Adiponectin blood, Adiponectin deficiency, Adult, Aged, Biomarkers blood, Coronary Artery Disease blood, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 epidemiology, Diabetes Mellitus, Type 2 immunology, Humans, Insulin Resistance immunology, Male, Metabolic Syndrome blood, Metabolic Syndrome epidemiology, Metabolic Syndrome immunology, Middle Aged, Obesity blood, Obesity epidemiology, Obesity immunology, Risk Factors, Chemokine CCL2 blood, Coronary Artery Disease epidemiology, Coronary Artery Disease immunology, Interleukin-8 blood
- Abstract
Background: Although many studies have shown that the metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) both are associated with chronic inflammatory state and are risk factors for coronary artery disease (CAD), it is still unclear which condition is a more important contributor to the increased production of inflammatory chemokines. The purpose of this study was to assess monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels and their association with insulin resistance and adiponectin concentrations in CAD patients, who were categorized as having T2DM, MS, or neither., Methods: CAD male patients were categorized into three groups: 24 non-obese patients with T2DM (D), 24 obese patients with MS (M) and 24 patients without T2DM or MS (W). 20 healthy subjects were selected as controls (C). Insulin resistance was assessed by the HOMA-IR method, but serum MCP-1, IL-8, and adiponectin levels were measured by xMAP technology., Results: Serum levels of MCP-1 and IL-8 in D and M groups were increased in comparison with W and C groups (p<0.001, p<0.01), but the increase in the M group was significantly higher than that in the D group (p<0.05, p<0,001), besides MCP-1 and IL-8 concentrations were correlated with HOMA-IR indexes (r=0.52; r=0.49, p<0.0001) and adiponectin levels (r=-0.59, p<0.0001). The M group demonstrated a diminution in the adiponectin level (p<0.01) and pronounced increase of HOMA-IR in comparison with the other three groups (p<0.01)., Conclusion: Obese CAD patients with MS have a more pronounced increase of MCP-1, IL-8 and HOMA-IR and more decreased adiponectin levels than non-obese CAD patients without MS.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.